In 2023, the mortality rate for trachea, bronchus, or lung malignant neoplasms among females in Brazil stood at 18.1 per hundred thousand women, standardized rates. From 2024, the forecast projects a gradual increase in mortality rates, with 18.2 in 2024, rising to 19.1 by 2028. The year-on-year percentage increase from 2024 to 2028 averages around 1.1%, indicating a consistent upward trend. The Compound Annual Growth Rate (CAGR) over this period is approximately 1.1%, pointing to a slow but steady increase in mortality rates.
Future trends to watch include potential impacts of healthcare initiatives, improvements in early detection and treatment methods, and changes in smoking prevalence, as these could significantly influence lung cancer mortality rates in Brazil.
